Recruitment

Recruitment Status
Enrolling by invitation
Estimated Enrollment
Same as current

Summary

Conditions
Osteoarthritis (Knee)
Type
Interventional
Phase
Phase 4
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Data Collection: Data will be collected from the patient's medical record after discharge Variables include: Age Sex BMI UPAT score (Universal Pain Assessment Tool)- this is assessed hourly postoperatively by nursing staff on Orthopedics Unit Patient's assessment of acceptability of pain UPAT score ...

Data Collection: Data will be collected from the patient's medical record after discharge Variables include: Age Sex BMI UPAT score (Universal Pain Assessment Tool)- this is assessed hourly postoperatively by nursing staff on Orthopedics Unit Patient's assessment of acceptability of pain UPAT score as assessed by physical therapy pre and post therapy sessions Duramorph dose Time patient arrived on the Orthopedic Unit Length of ambulation during physical therapy sessions Amount of supplementary opioids (measured in morphine equivalents) Use of anti-emetics Any complications of surgery including venous thromboembolic event, cardiac event, bleeding event Length of hospital stay The pharmacist will randomize patients to either study arm, prepare the injection and maintain dispensing records.

Tracking Information

NCT #
NCT02570503
Collaborators
Not Provided
Investigators
Principal Investigator: Gregory Golladay, MD Virginia Commonwealth University